Browsing by Author "Rojas, Manuel"
Now showing items 1-2 of 2
-
Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19
Anaya, Juan-Manuel; Monsalve, Diana M.; Rojas, Manuel; Rodríguez, Yhojan; Montoya-García, Norma; Mancera-Navarro, Laura Milena; Villadiego-Santana, Ana María; Rodríguez-Leguizamón, Giovanni; Acosta-Ampudia, Yeny; Ramírez-Santana, Carolina-2021-03 -
Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study
Rojas, Manuel; Rodríguez, Yhojan; Hernández, Juan Carlos; Díaz-Coronado, Juan C.; Daza Vergara, José Alejandro; Posada Vélez, Verónica; Porras Mancilla, Jessica; Araujo, Iván; Torres Yepes, Jairo; Briceño Ricaurte, Oscar; Pardo-Oviedo, Juan Mauricio; Monsalve, Diana M.; Acosta-Ampudia, Yeny; Ramírez-Santana, Carolina; Gaviria García, Paula; Acevedo Landinez, Lina; Duarte Correales, Luisa; Grass, Jeser Santiago; Ricaurte Pérez, Cristian; Salguero López, Gustavo; Mateus, Nataly; Mancera, Laura; Rengifo Devia, Ronald; Orjuela, Juan Esteban; Parra-Moreno, Christian R.; Alfonso Buitrago, Andrés; Ordoñez, Inés Elvira; Fabra Osorio, Claudia; Ballesteros, Nathalia; Patiño, Luz H.; Castañeda, Sergio; Muñoz, Marina; David Ramírez, Juan; Bastard, Paul; Gervais, Adrian; Bizien, Lucy; Casanova, Jean-Laurent; Camacho, Bernardo; Gallo, Juan Esteban; Gómez, Oscar; Rojas-Villarraga, Adriana; Pérez, Carlos E.; Manrique, Rubén; Mantilla, Rubén D.; Anaya, Juan-ManuelBackground Convalescent plasma (CP) has been widely used to treat COVID-19 and is under study. However, the variability in the current clinical trials has averted its wide use in the current pandemic. We aimed to evaluate ...2022-06